WCD-Dubai-2011

International Diabetes Federation (IDF) 21st World Congress. Dubai. 4-8 de diciembre de 2011.



La primera presentación del bypass gastroileal en un congreso mundial de la diabetes de la International Diabetes Federation (IDF) tuvo lugar en Dubai en febrero de 2012.

Texto de la presentación:

Laparoscopic gastroileal bypass for diabetes treatment in nonmorbidly obese patients.

Resa JJ, Lagos J, Valero M, Toural ME, Ferrando J.

Department of Metabolic and Bariatric Laparoscopic Surgery, Montpellier Clinic, Zaragoza, Spain.


BACKGROUND: Since 2000 year we have perfored more than 500 laparoscopic biliopancreatic diversion without gastrectomy (LBPD-G) for morbid obesity treatment with excellent results. In 2008 year we began to treat diabetes in nonmorbidly obese patients through LBPD-G with 200 cm alimentary limb plus 200 cm common limb with 92% of diabetes resolution. To simplify the technic and aboid steatorrhoea we developed the laparoscopic gastrileal bypass, an operation between biliopancreatic diversion and minigastric bypass.
METHODS: Prospective study on oral glucose loads in 30 severe diabetic patients (body mass index [BMI] >30 and <35, HbA1C >7.5%) before and at 1, 3, 6, 12, 18 and 24 months after laparoscopic gastroileal bypass with a horizontal gastric trasection and 300 cm gastroenteral anastomosis from ileocecal valve.
RESULTS: Of the 30 patients enrolled, the mean age was 47.8 years, mean BMI was 33.58, mean fasting plasma glucose was 182.7 and mean HbA1C was 8.9. The mean BMI at 1, 3, 6, 12, 18 and 24 months after operation were 30.26, 28.47, 27.39, 26.52, 25.69 and 25.62, respectively. The mean HbA1C at 1, 3, 6, 12, 18 and 24 months after operation were 7.3, 5.8, 5.9, 5.5, 5.7 and 5.6, respectively. Resolution of type 2 diabetes was achieved in 21 patients at 3 months and 29 at 12 months after gastroileal bypass. The mean operating time was 30 minutes, without complications and mortality. Single port laparoscopic was accomplished in 6 patients.

CONCLUSION: Laparosopic gastroileal bypass seems to be a promising procedure for the control of T2DM and the metabolic syndrome.


Poster presentado en el WDC de febrero de 2012 en Dubai.
Ambiente del congreso y exposición.


El índice de participación y médicos potenciales que pudieron ver estos resultados es enorme. Asistieron 15.100 profesionales de 176 países, con 391 ponentes.